RAPT Therapeutics (RAPT) Current Leases (2022 - 2024)
Historic Current Leases for Therapeutics (RAPT) over the last 3 years, with Q3 2024 value amounting to $2.5 million.
- Therapeutics' Current Leases rose 556.49% to $2.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.5 million, marking a year-over-year increase of 556.49%. This contributed to the annual value of $2.4 million for FY2023, which is 1275.91% up from last year.
- Latest data reveals that Therapeutics reported Current Leases of $2.5 million as of Q3 2024, which was up 556.49% from $2.6 million recorded in Q2 2024.
- Therapeutics' 5-year Current Leases high stood at $2.6 million for Q2 2024, and its period low was $1.5 million during Q1 2022.
- For the 3-year period, Therapeutics' Current Leases averaged around $2.2 million, with its median value being $2.3 million (2023).
- Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 5522.29% in 2023, then surged by 556.49% in 2024.
- Over the past 3 years, Therapeutics' Current Leases (Quarter) stood at $2.2 million in 2022, then grew by 12.76% to $2.4 million in 2023, then increased by 3.06% to $2.5 million in 2024.
- Its last three reported values are $2.5 million in Q3 2024, $2.6 million for Q2 2024, and $2.5 million during Q1 2024.